Polish Pharmaceuticals & Biotech Potentially Undervalued Companies

Selvita

Market Cap: zł567.2m

Operates as a contract research organization worldwide.

Bayer

Market Cap: zł19.8b

Operates as a life science company worldwide.

Krka d. d

Market Cap: zł5.2b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.

Stem Cells Spin

Market Cap: zł7.3m

Operates as a biotechnology company in Poland.

Mabion

Market Cap: zł147.6m

A biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland.